Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)- 2- benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: Comparison of effects between KAD-1229 and gliclazide

Journal of Pharmacology and Experimental Therapeutics

Volumn 269, Issue 2, 1994, Pages 489-495

  Ohnota, H ^a   Koizumi, T ^a   Tsutsumi, N ^a   Kobayashi, M ^a   Inoue, S ^a   Sato, F ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RECEPTOR; GLICLAZIDE; MITIGLINIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES CONTROL; DOG; DOSE RESPONSE; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMAL; BIOLOGICAL TRANSPORT; CELLS, CULTURED; COMPARATIVE STUDY; DOGS; GLICLAZIDE; GLYBURIDE; HYPOGLYCEMIC AGENTS; INDOLES; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; MICROSOMES; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; RUBIDIUM;

EID: 0028284740     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)